Home About Us Research & Development News Careers Contact Us
 

News Highlights

January 30, 2012
Concert Pharmaceuticals to Present at Epilepsy Pipeline Update Conference

January 18, 2012
New Patents Expand Concert Pharmaceuticals’ Patent Estate of Deuterium-Based Therapeutics; 25 Patents Issued Worldwide

November 15, 2011
Concert Pharmaceuticals Announces NIH Research Collaboration for Rare and Neglected Diseases

November 14, 2011
Concert Presents Phase 1 Data for CTP-499 at ASN Kidney Week Meeting; Supports Advancement into Phase 2 in Diabetic Nephropathy Patients

more...

 

Welcome to Concert

Concert uses deuterium-based chemistry to create and develop highly differentiated new medicines by leveraging decades of pharmaceutical and clinical experience to reduce time, risk and expense.

Concert in the news... a selection of news stories featuring Concert.

Healthcare Global Magazine
Concert Pharmaceuticals Changes the Industry with Deuterium

Upcoming Events

Concert will present at Cowen & Company 32nd Annual Health Care Conference on March 6, 2012 at 11:30 a.m. in Boston

Business Development/Strategic Partnering

Concert business development will present at BioNetwork East 2012, March 5-7, 2012 in Miami, FL



 

 
  ©2009 Concert Pharmaceuticals, Inc.
Design by Digizyme
 
Home     Sitemap